Comparative studies on the in vivo effects of tartar emetic, vitamin B 6 , and the chelating agent 2,3-dimercaptopropanol (BAL) on the functional capacity of the tryptophan-niacin pathway in patients with schistosomiasis.
D000085:Acetates / Q000652:urine; D000293:Adolescent; D000618:Aminohippuric Acids / Q000652:urine; D000965:Antimony / Q000627:therapeutic use; D002648:Child; D004112:Dimercaprol / Q000627:therapeutic use*; D004639:Emetics / Q000627:therapeutic use*; D005965:Glucuronates / Q000652:urine; D006801:Humans; D007200:Indican / Q000652:urine; D007539:Isonicotinic Acids / Q000652:urine; D007736:Kynurenic Acid / Q000652:urine; D007737:Kynurenine / Q000652:urine; D008297:Male; D009539:Nicotinic Acids / Q000378:metabolism*; D011736:Pyridoxine / Q000627:therapeutic use*; D012548:Schistosoma haematobium; D012552:Schistosomiasis / Q000188:drug therapy / Q000378:metabolism* / Q000652:urine; D013644:Tartrates / Q000627:therapeutic use; D014364:Tryptophan / Q000378:metabolism*; D014977:Xanthurenates / Q000652:urine; D062367:ortho-Aminobenzoates / Q000652:urine
D000085:Acetates; D000618:Aminohippuric Acids; D004639:Emetics; D005965:Glucuronates; D007539:Isonicotinic Acids; D009539:Nicotinic Acids; D013644:Tartrates; D014977:Xanthurenates; D062367:ortho-Aminobenzoates; D004112:Dimercaprol; D007737:Kynurenine; D014364:Tryptophan; D000965:Antimony; D007736:Kynurenic Acid; D011736:Pyridoxine; D007200:Indican